Cervical stenosis in postmenopausal women when mechanical dilation has not restored uterine access
Clinical Scenario
This protocol is for patients with stricture or stenosis of the cervix uteri who are postmenopausal or receiving gonadotropin-releasing hormone (GnRH) analog therapy. Both situations result in a hypoestrogenic state, which substantially limits the effectiveness of standard cervical preparation approaches.
When the Initial Approach Has Not Worked
Mechanical cervical dilation using Hegar or Pratt dilators — with or without preparatory vasopressin injection into the cervix — is the first-line intervention. When this approach fails to restore patency of the cervical canal and does not allow entry into the uterine cavity, escalation to a surgical approach is indicated.
Next-Line Approach (Partial Overview)
The evidence-based next step involves an office-based hysteroscopic surgical procedure, recognised as the gold standard for this setting. The specific technique is selected according to the nature of the obstruction encountered. The full decision algorithm, procedural options, and clinical details are available in the complete protocol.
Treatment Goal
Successful access to the uterine cavity with restored patency of the cervical canal.
References
DOI: 10.1007/s00404-023-07126-1
In postmenopausal women and those treated with gonadotropin-releasing hormone analogs, misoprostol has a decreased effect since prostaglandins require estrogen to generate their cervical ripening effects, and postmenopausal patients are in a hypoestrogenic state.
This minimally invasive procedure represents the gold standard approach for the management of patients with cervical stenosis.
The main objective of both medical and surgical treatments for cervical stenosis is to restore the patency of the cervical canal.
View source ↗